Shaily Engineering Plastics Limited has announced the signing of a substantial manufacturing and commercial supply agreement with a large domestic pharmaceutical company. The contract, valued at approximately Rs. 423 crores, is for the supply of pen injectors. The entire supply commitment is structured to occur over a significant period of four years, solidifying Shaily’s role as a key manufacturing partner in the medical device sector.
Significant Contract Awarded to Shaily Engineering
Shaily Engineering Plastics Limited (SEPL) has formally disclosed the signing of a major supply contract, pursuant to recent disclosure requirements. The agreement was executed with a Large Domestic Pharma Company, whose identity remains confidential due to non-disclosure clauses. The core purpose of the contract is the supply of pen injectors, indicating a strong business focus on specialized medical/healthcare components.
Key Terms and Contract Value
The financial scope of this agreement is substantial. The broad consideration or size of the order is approximately Rs. 423 crores. This business is structured as a long-term commitment, with the time period for execution and supply spanning over a period of four years. The nature of the engagement is classified as a Manufacturing & Commercial Supply Agreement, confirming SEPL’s role as a primary manufacturer.
Domestic Nature of Agreement
The entity awarding the contract is confirmed to be a Domestic Entity, and the transaction itself is classified as entirely Domestic. Furthermore, the company confirmed that neither its promoter group nor any group companies hold any interest in the awarding entity, ensuring the transaction does not involve promoter group interests. The transaction is also Not Applicable in terms of being a related party transaction.
The official intimation was issued by CS Harish Punwani, Company Secretary & Compliance Officer, on February 25, 2026.
Source: BSE
